Ergomar User Reviews & Ratings
Ergomar has an average rating of 9.0 out of 10 from a total of 1 reviews on Drugs.com. 100% of reviewers reported a positive experience, while 0% reported a negative experience.
Condition | Avg. Rating | Reviews | Compare |
---|---|---|---|
Migraine | 1 reviews for Migraine | 93 medications |
See also:
Ubrelvy
Ubrelvy (ubrogepant) tablets are used for the acute treatment of migraine. Includes Ubrelvy side ...
Nurtec ODT
Nurtec ODT (rimegepant) is used to treat acute migraines and prevent episodic migraines, by ...
Qulipta
Qulipta is used to help prevent episodic or chronic migraine headaches in adults. Qulipta is an ...
Celebrex
Celebrex is a nonsteroidal anti-inflammatory drug used to treat pain or inflammation. Learn about ...
Botox
Botox is used cosmetically to reduce facial lines and wrinkles and for medical purposes for ...
Verapamil
Verapamil is used to treat hypertension (high blood pressure), angina (chest pain), and certain ...
Sumatriptan
Sumatriptan is a prescription medicine used to treat acute migraine headaches and cluster ...
Metoclopramide
Metoclopramide is used short-term to treat heartburn caused by gastroesophageal reflux. Learn about ...
Celecoxib
Celecoxib is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain or inflammation ...
Topiramate
Learn about topiramate, an anticonvulsant used for seizures, migraine prevention, and weight loss ...
Are you taking this medicine?
Your review helps others make informed decisions.More about Ergomar (ergotamine)
- Check interactions
- Compare alternatives
- Reviews (1)
- Imprints, shape & color data
- Side effects
- Dosage information
- During pregnancy
- Drug class: antimigraine agents
- Breastfeeding
- En español
For Migraine "Medications with ergotamine are the only thing that have ever stopped a migraine at the visual disturbance stage for me. I used to take Cafergot, but that took forever if I had just eaten. Ergomar dissolves under the tongue and works fast. It's the best thing ever for a 'classic' migraine."